RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/AB90BEAD4C637F8E3D207DF082FC5451C5D6868CB8E2BD438C56EE0129A3DEF0DEC99288974EEB5D9416A688C508989Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/AB90BEAD4C637F8E3D207DF082FC5451C5D6868CB8E2BD438C56EE0129A3DEF0DEC99288974EEB5D9416A688C508989Bhttp://www.w3.org/2000/01/rdf-schema#comment"Hepatocellular carcinoma (HCC) tumors with low expression of PRDX4 had higher ROS levels malignancy and associated with reduced overall survival. In HCC cell lines its knockdown led to increased intracellular ROS level and suppressed cell proliferation inducing cell death. These results indicate that PRDX4 has an inhibitory effect in the initiation of HCC but a dual (inhibitory or promoting) role in the progression."xsd:string
http://purl.uniprot.org/uniprot/#_962D0069F0291CA45301BC20EAD46C49AFF9BFAEAE8B24149E659332A1BBA2474CE4B6CA9F20E0579532A80B9A831429http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/AB90BEAD4C637F8E3D207DF082FC5451C5D6868CB8E2BD438C56EE0129A3DEF0DEC99288974EEB5D9416A688C508989B
http://purl.uniprot.org/uniprot/V9HW63http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/AB90BEAD4C637F8E3D207DF082FC5451C5D6868CB8E2BD438C56EE0129A3DEF0DEC99288974EEB5D9416A688C508989B
http://purl.uniprot.org/uniprot/#_V9HW63-mappedCitation-29687726http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/AB90BEAD4C637F8E3D207DF082FC5451C5D6868CB8E2BD438C56EE0129A3DEF0DEC99288974EEB5D9416A688C508989B